LightPath Technologies heads into mid-July carrying nearly 20% of its free float sold short, a stock down 19% in a month, and a major insider who has been cashing out since spring — a setup where the bearish data and the bullish Street case are pointing in opposite directions.
Short interest is the headline number this week. It has nearly doubled since early June, climbing from roughly 4.9 million shares to 8.9 million — an 83% jump in one month that now leaves SI at 19.6% of the free float. That is a genuinely elevated position for a small-cap optical components maker. The pace of the build accelerated sharply around June 29, adding more than 2 million shares in a single session, before easing back about 5% this past week to settle near current levels. Despite the size of the short book, borrow conditions remain surprisingly relaxed. Cost to borrow has actually fallen over the month to just 0.47%, and availability is running at 174% — meaning there are roughly 1.7 shares available to lend for every share already borrowed. Shorts face no squeeze pressure from the lending market at current levels. Options lean modestly more defensive, with the put/call ratio at 0.71, running about 1.3 standard deviations above its 20-day average of 0.62 — elevated caution, not panic.
The Street, however, remains unanimously bullish. Every analyst covering LPTH carries a Buy rating, and targets have been ratcheted higher at each earnings cycle. The most recent action came from Canaccord Genuity in May, lifting its target to $16.50 after the quarterly print. The mean target of $15.98 implies roughly 39% upside from Tuesday's close of $11.52. The bull case rests on a $100 million-plus backlog, growing defense and security demand, and the BlackDiamond infrared optics product gaining traction against traditional Germanium materials. Bears point to negative EBITDA (EV/EBITDA is deeply negative), dilution risk, and customer concentration. The ORTEX short score has drifted gently higher through July to 63.4, and the factor picture is mixed: EPS momentum over 30 days ranks in the 100th percentile — the strongest possible reading — while the 90-day reading falls to the 1st percentile, flagging volatility in estimate revisions rather than a clean trend.
The most concrete signal of the past two months is in the insider activity, and it cuts against the bullish analyst consensus. North Run Strategic Opportunities Fund, a 10%-plus owner with a board seat, sold more than 4.2 million shares between mid-March and early June — culminating in a single $50 million block sale on June 3 at $14 per share. North Run's reported holding has dropped from above 5% to approximately 4.7% of shares outstanding, and the cumulative net insider outflow over 90 days comes to roughly $60 million. That is a material reduction. A nominal $1,745 purchase by CEO Shmuel Rubin in late March sits in the data but does not materially change the picture. Institucional ownership is otherwise broadening — Vanguard Capital Management, Goldman Sachs, and Tema ETFs all added new or substantially larger positions in Q1 and Q2 — which partially offsets the North Run reduction.
Recent earnings reactions carry a cautionary note. The May quarterly print produced a 5% one-day drop before recovering strongly over the following week. An earlier release in the same month saw the stock fall more than 10% on the day, with losses extending to 5.6% by day five. The next earnings event is pencilled in for September 17, leaving roughly two months for the current positioning — heavy shorts, fading stock, but loose borrow — to resolve in either direction before results add another data point.
With Q3 results nine weeks out, the tension to watch is whether short interest stabilises at current levels or resumes its climb now that the initial post-earnings adjustment has settled, and whether North Run's exit slows or continues as the stock trades further below its spring selling prices.
See the live data behind this article on ORTEX.
Open LPTH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
